Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2006-04-18
2006-04-18
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C424S451000, C424S457000, C424S458000, C424S468000, C424S472000, C514S226500, C514S277000, C514S365000, C514S374000, C514S410000, C514S411000, C514S454000, C514S568000, C514S569000, C514S570000, C514S617000, C514S646000, C514S685000, C514S686000, C514S716000, C514S717000, C514S721000, C514S727000, C514S964000
Reexamination Certificate
active
07030162
ABSTRACT:
The invention is directed to pharmaceutical compositions useful in the treatment of migraine. The compositions contain metoclopramide and one or more NSAIDs in unit dosage form. By selecting NSAIDs that are non-acidic or segregating the metoclopramide and NSAID, the storage life of the compositions has been increased. Also disclosed are coordinated dosage forms for the sequential release of drugs. The invention encompasses methods of treating migraine using any of these dosage forms.
REFERENCES:
patent: 2099402 (1937-11-01), Keller
patent: 4024279 (1977-05-01), Zor et al.
patent: 4235971 (1980-11-01), Howard et al.
patent: 4380540 (1983-04-01), Poyser et al.
patent: 4664915 (1987-05-01), Simonian
patent: 4999226 (1991-03-01), Schock et al.
patent: 5037823 (1991-08-01), Jones et al.
patent: 5055306 (1991-10-01), Barry et al.
patent: 5155105 (1992-10-01), Jones et al.
patent: 5288507 (1994-02-01), Sims et al.
patent: 5415870 (1995-05-01), Gergely et al.
patent: 5437874 (1995-08-01), Bru et al.
patent: 5573776 (1996-11-01), Harrison et al.
patent: 5681583 (1997-10-01), Conte et al.
patent: 5885616 (1999-03-01), Hsiao et al.
patent: 6077539 (2000-06-01), Plachetka et al.
patent: 6106862 (2000-08-01), Chen et al.
patent: 6479551 (2002-11-01), Plachetka et al.
patent: 881 967 (1980-06-01), None
patent: 1165242 (1984-04-01), None
patent: 2020018 (1990-06-01), None
patent: 0 774 253 (1997-05-01), None
patent: 0 823 255 (1998-02-01), None
patent: 58-8020 (1983-01-01), None
patent: WO 95/22947 (1995-08-01), None
STN/CAS online, file EMBASE, Acc. No. 1999161935, (Mandell, Cleveland Clinic Journal of Medicine (1999), 66/5, pp. 285-292), Abstract.
Remington's Pharmaceutical Sciences (17th Ed. 1985), p. 1111.
EP 0774253, abstract (1997).
BE 881967, abstract (1980).
STN/CAS online, file EMBASE, Acc. No. 1999161935 (Mandell,Cleveland Clinic Journal of Medicine 66:285-292 (1999), Abstract.
Albibi, et al., Metoclopramide: Pharmacology and Clinical Application,Ann. Int. Med. 98:86-95 (1983).
Andersson, et al., “Double-Blind Study of Naproxen vs. Placebo in the Treatment of Acute Migraine Attacks,”Cephalalgia 9:29-32 (1989).
Bateman, et al., “Extrapyramidal Reactions to Metoclopramide and Prochlorperazine,”Quart J. Med. 71:307-311 (1989).
Baumel, Migraine: A Pharmacologic Review with Newer Options and Delivery Modalities,Neurology 44:S13-S17 (1994).
Becker, et al., “Pharmacokinetic Aspects of a Combination of Metoclopramide and Paracetamol. Results of a Human Kinetic Study and Consequences for Migraine Patients,”Arzneimittelforschung 42:552-555 (1992) (including English Language Abstract).
Boureau, et al., “Comparison of Subcutaneous Sumatriptan with Usual Acute Treatments for Migraine,”Eur. Neurol. 35:264-269 (1995).
Capobianco, et al., “An Overview of the Diagnosis and Pharmacologic Treatment of Migraine,”Mayo Clin. Proc. 71:1055-1066 (1996).
Chabriat, et al., “Combined Oral Lysine Acetylsalicylate and Metoclopramide in the Acute Treatment of Migraine: A Multicentre Double-Blind Placebo-Controlled Study,”Cephalalgia 14:297-300 (1994).
Chabriat, et al., “Combined Aspirin amd Metoclopramide in the Acute Treatment of Migraine Attacks: A Review,”Headache Quarterly 8:118-121 (1997).
Chrubasik, “Paracetamol and Metoclopramide in Fixed Combination,”Med. Montasschr. Pharm. 19:110 (1996) (German Language).
Cohen, et al., “Migraine Headache and the Managed Care Formulary,”Drug Benefit Trends8:28-30,33-34,41 (1996).
Consumer Assoc., “Metoclopramide/Analgesic Combinations for Migraine,”Drug and Therapeutics Bulletin 18::95-96 (1980).
Dechant, et al., “Sumatriptan: A Review of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in the Acute Treatment of Migraine and Cluster Headache,”Drugs 43:776-798 (1992).
Diamond, et al., “Do Non-Steroidal Anti-Inflammatory Agents Have a Role in the Treatment of Migraine Headaches?,”Drugs 37:755-760 (1989).
Edmeads, “Four Steps in Managing Migraine,”Postgraduage Medicine 85:121-124, 127-128, 131, 132-134 (1989).
Eldor, et al., “Ergotamine-Metoclopramide for Migraine: Is It Enough?,”Cephalalgia 32:466 (1992).
Ellis, et al., “The Efficacy of Metoclopramide in the Treatment of Migraine Headache,”Ann. Emerg. Med. 22:191-195 (1993).
Gamst, “Oral Naproxen Formulations,”Scand. J. Gastroenterol. 24:44-47 (1989).
Ganzini, et al., “The Prevalence of Metroclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders,”Arch. Intern. Med. 153:1469-1475 (1993).
Greiff, et al., “Pharmacokinetic Drug Interactions with Gastrointesinal Motility Modifying Agents,”Clin. Pharmacokinetics 27:447-461 (1994).
Gupta, et al., “Effect of Metoclopramide on Gastric Ulceration and Secretion in Albino Rats,”Arch Int. Pharmacodyn. 297:158-165 (1989).
Harrington, et al., “Metoclopramide: An Updated Review of Its Pharmacological Properties and Clinical Use,”Drugs 25:451-494 (1983).
Hoemecke, et al., “Treatment of Migraine Attacks: Combination of Dihydroergotamine Tartrate and Paracetamol in Comparison with Individual Drugs and Placebo,”Med. Klin. 88:642-648 (1993) (including English Language Abstract).
Hughes, “Metoclopramide in Migraine Treatment,”Med. J. Australia 2:580 (1977).
Hugues, et al., “Repeated Doses of Combined Oral Lysine Acetylsalicylate and Metoclopramide in the Acute Treatment of Migraine,”Headache 37:454-454 (1997).
Johnson, et al., “Naproxen Sodium in the Treatment of Migraine,”Cephalalgia 5:5-10 (1985).
Kaa, et al., “Emergency Department Resource Use by Patients with Migraine and Asthma in a Health Maintenance Organization,”Ann. Pharmacotherapy 29:251-256 (1995).
Kandler, et al., “Analgesic Action of Metoclopramide in Prosthetic Hip Surgery,”Acta. Anaesthesiol. Scand. 37:49-53 (1993).
Kirby, et al., “Effect of Metoclopramide, Bethanechol, and Loperamide on Gastric Residence Time, Gastric Emptying, and Mouth-Cecum Transit Time,”Pharmacotherapy 9:226-231 (1989).
Klapper, “Toward a Standard Drug Formulary for the Treatment of Headache,”Headache 35:225-227 (1995).
Kumar, “Recent Advances in the Acute Management of Migraine and Cluster Headaches,”J. Gen. Intern. Med. 9:339-348 (1994).
Manniche, et al., “The Pharmacokinetics of the Individual Constituents of an Aspirin-Metoclopramide Combination (‘Migravess’),”Curr. Med. Res. Opin. 9:153-156 (1984).
Mathew, “Serotonin 1D(5-HT1D) Agonists and Other Agents in Acute Migraine,”Advances in Headache 15:61-81 (1997).
Mohnot, “Treatment of Intractable Headaches,”Neurology 36:101 (1986).
Ottervanger, “Ketorolac for Severe Migraine,”Med. Sci. Bul. 26:49 (1994).
Peroutka, “Beyond Monotherapy: Rational Polytherapy in Migraine,”Headache 38:18-22 (1998).
Peroutka, “Dopamine and Migraine,”Neurology 49:650-656 (1997).
Pfaffenrath, et al., “Analgesics and NSAIDs in the Treatment of the Acute Migraine Attack,”Cephalalgia 15:14-20 (1995).
Pini, et al., “Disposition of Naproxen after Oral Administration During and Between Migraine Attacks,”Headache 33:191-194 (1993).
Plosker, et al., “Sumatriptan: A Reappraisal of Its Pharmacology and Therapeutic Efficacy in the Acute Treatment of Migraine and Cluster Headache,”Drugs 47:622-651 (1994).
Pradalier, et al., “Treatment Review: Non-Steroid Anti-Inflammatory Drugs in the Treatment and Long-Term Prevention of Migraine Attacks,”Headache 28:550-557 (1988).
Pryse-Phillips, et al., “Guidelines for the Diagnosis and Management of Migraine in Clinical Practice,”Can. Med. Assoc. J. 156:1273-1287 (1997).
Ross-Lee, et al., “Single-Dose Pharmacokinetics of Metoclopramide,”Eur. J. Clin. Pharmacol. 20:465-471
Chowhan Zakauddin T.
Plachetka John R.
Choi Frank
Fitch Even Tabin & Flannery
Pak John
POZEN Inc.
Sanzo Michael A.
LandOfFree
Treatment of migraine headache does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of migraine headache, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of migraine headache will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3616843